Skip to main content
Premium Trial:

Request an Annual Quote

Michael Miller, Claes Wilhelmsson, Stephen Fodor, Susan Eddins, Juli Klemm

Premium

Michael Miller has joined Picoliter of Mountain View, Calif., as vice president of research and development. Most recently, Miller was department director of genomics systems development at Amersham Biosciences. Prior to that, he held several positions at Molecular Dynamics, which was acquired by Amersham. Miller holds a BS in mechanical engineering from San Jose State University. Picoliter develops systems for handling small amounts of liquids that it says have applications in microarray research.

Claes Wilhelmsson has become chairman of the board of Gyros, the Swedish company announced this week. Wilhelmsson joins the company from AstraZeneca, where he was executive director and head of research and development. He is also a senior advisor to Investor Growth Capital, a wholly-owned subsidiary of the company Investor. Gyros develops miniaturized laboratory applications, including a microlaboratory in the form of a compact disk.

Stephen Fodor is this year’s winner of Genome Technology magazine’s All Stars award in the category “Most Masterful in Microarrays.” Genome Technology is the sister publication of BioArray News. Fodor was selected by readers of the magazine and receives the award for his invention and commercialization of the high-density DNA microarray. Affymetrix also won the award in the category “Company or Institute of the Year.”

Susan Eddins has been appointed as head of worldwide marketing at Illumina of San Diego. In her new position, she will be responsible for marketing and product management of the company’s high-throughput BeadArray and Oligator technology platforms. Prior to joining Illumina, Eddins was director of genomic assays at Applied Biosystems. Before that, she worked in the electronic design automation industry.

Prior to joining Illumina, Eddins was director of genomic assays at Applied Biosystems. Before that, she worked in the electronic design automation industry.

Juli Klemm joins 3rd Millennium as senior project scientist. She joins the company from Incyte Genomics, where she was director of scientific project management. Klemm has a BS in biology from the University of Utah and a PhD in biology from MIT.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.